Equity
●
Pharma & Health Care
Current NAV
₹16.45
Expense Ratio
2.35%
Min SIP
₹500
Fund Size
₹227Cr
Min Investment
₹5.00K
Lock In
NA
Scheme Information Document
Exit load: 1% on or before 12M, Nil after 12M
Alpha
-0.04%
Beta
0.92
Sharpe Ratio
0.302914
Risk
21.23%
Above numbers are based upon past 3 years
Would have become
₹1,49,748.59
(-2.98)%
| Name | Holding(%) |
| Name | Sector(%) |
| Name | Assets(%) |
Rohan Korde
ITI Pharma & Healthcare FundTotal assets under management
₹9.86L Crores
Date of incorporation
14 May 2018
Ans.
Go to the Rupeezy App
Ans. The ITI Pharma & Healthcare Fund has an AUM of ₹235.68 Cr as on 9/8/2025. The scheme has delivered CAGR returns for the past 3 years against a category average of 23.56%. The risk is Very High against the category average of 88.65.
Ans. Mutual fund taxation depends on the scheme type and investment holding period.
Taxation on equity funds: For equity funds (funds that invest at least 65% of the corpus in Indian stocks), if the holding period is more than 12 months, LTCG (Long Term Capital Gains) tax is applicable. For units sold within 12 months of purchase, STCG (Short Term Capital Gains) Tax is applicable.
LTCG tax on equity-oriented schemes is 12.5% on capital gains over ₹1.25 lakh (as per the latest update in Budget 2024).
STCG tax applicable on the sale of units of equity-oriented mutual fund schemes is 20%.
Ans. There is no lock-in period applicable on ITI Pharma & Healthcare Fund.
Ans. The expense ratio of ITI Pharma & Healthcare Fund is 2.35%.